Enovis enters binding offer to acquire eCential Robotics

GRENoble, France and FRANKLIN, Tennessee - Enovis Corporation has made a binding offer to acquire eCential Robotics, a company specializing in surgical robotics technology, according to a recent press release. The acquisition, subject to regulatory approvals, is anticipated to conclude during the fourth quarter of 2026. Following the completion of the information and consultation process with eCential Robotics' works council, as mandated by French law, the two entities will proceed to sign a definitive purchase agreement.

eCential Robotics has created a modular platform for robotic-assisted surgery, with its Op.n platform combining surgical navigation and active robotics. This platform has received FDA 510(k) clearance for spine surgery in the United States. Clément Vidal, Chief Executive Officer of eCential Robotics, emphasized the company's focus on providing surgeons with user-friendly, state-of-the-art technology to enhance surgical workflows and ultimately, improve patient outcomes.

Enovis CEO Damien McDonald explained that the acquisition aligns with the company's strategy of incorporating externally developed innovation into its existing technology ecosystem. The surgical robotics platform will be integrated into Enovis' ASTRA enabling technology platform. eCential Robotics will maintain its collaboration with spine implant partners in the deployment of its Op.n Spine Navigation and Robotic Guidance Platform.

eCential Robotics is based in Gières, France, with US commercial operations in Franklin, Tennessee. The financial advisory firm Apparius is representing eCential Robotics, while Goodwin France and Cabinet Franck Robert are serving as legal counsel. The financial details of the transaction have not been disclosed.